Company-wide revenue
Reported revenue in 2021 ¥2.77T Reported revenue in 2025 ¥2.33T
- growth amount
- −¥436.81B
- growth annualized
- -4.2%
- growth total
- -15.8%
Japanese company profile · 4005
In its FY2025 public filing, SUMITOMO CHEMICAL COMPANY, LIMITED reports Agro and Life Solutions, ICT and Mobility Solutions, Advanced Medical Solutions, Essential and Green Materials, and 1 other reported businesses. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 住友化学株式会社
English company name recorded in Japan's EDINET filer data. English company name source
What does this company do?
SUMITOMO CHEMICAL COMPANY, LIMITED's largest reported business by revenue in FY2025 was Essential and Green Materials.
The business with the highest reported segment profit in FY2025 was Sumitomo Pharma.
FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.
Business structure
| Business | Revenue from external customers | Revenue share | Segment profit (loss) |
|---|---|---|---|
| Essential and Green Materials | ¥678.8B ↗ | 29.2% | ¥14.45B ↗ |
| ICT and Mobility Solutions | ¥574.16B ↗ | 24.7% | ¥53.04B ↗ |
| Agro and Life Solutions | ¥519.26B ↗ | 22.3% | ¥56.33B ↗ |
| Sumitomo Pharma | ¥451.93B ↗ | 19.4% | ¥108.44B ↗ |
| Advanced Medical Solutions | ¥58.6B ↗ | 2.5% | ¥2.82B ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.
Reported Revenue from external customers by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Agro and Life Solutions | — | — | — | ¥540.22B | ¥519.26B |
| ICT and Mobility Solutions | — | — | — | ¥607B | ¥574.16B |
| Advanced Medical Solutions | — | — | — | ¥62.15B | ¥58.6B |
| Essential and Green Materials | — | — | — | ¥899.03B | ¥678.8B |
| Sumitomo Pharma | — | — | — | ¥398B | ¥451.93B |
| Petrochemicals | ¥842.51B | ¥852.92B | ¥773.98B | — | — |
| Energy and Functional Materials | ¥316.39B | ¥342.46B | ¥300.26B | — | — |
| Information and Electronic Chemicals | ¥473.74B | ¥431.22B | ¥414.15B | — | — |
| Health and Crop Sciences Business | ¥473.78B | ¥598.39B | ¥545.97B | — | — |
| Pharmaceuticals | ¥591.71B | ¥584.87B | ¥342.74B | — | — |
| Essential Chemicals | ¥842.51B | ¥852.92B | ¥773.98B | — | — |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
Reported revenue in 2021 ¥2.77T Reported revenue in 2025 ¥2.33T
This describes a reported period; it is not a forecast.
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YAUO
View original filing ↗Ask about this company
The source document may be in Japanese.